Smoking cessation advice provided in 53 Norwegian pharmacies

International Journal of Pharmacy Practice

Volumn 12, Issue 4, 2004, Pages 179-184

  Granas, Anne G ^a   Haugli, Arild ^a   Horn, Anne M ^a  

^a Institute for Pharmacy Practice Research   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE GUM; NON PRESCRIPTION DRUG;

ARTICLE; CLINICAL PHARMACY; CONSUMER; HEALTH CARE QUALITY; HUMAN; LAW; MULTICENTER STUDY; NORWAY; PATIENT COUNSELING; PRIORITY JOURNAL; SCORING SYSTEM; SMOKING; SMOKING CESSATION; STATISTICAL SIGNIFICANCE;

EID: 9644270530     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357044472     Document Type: Article

References (30)

1. Shibuya K, Ciecierski C, Guindon E, Bettcher DW, Evans DB, Murray CJL. WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty. BMJ 2003;327:154.
2. Peto R, Lopex AD, Boreham J, Thum M, Heath C Jr. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 2003;339:1268-78.
3. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436-42.
4. Asvall JE. The WHO wants governments to encourage people to stop smoking. BMJ 1997;314:1688.
5. Taylor AL, Bettcher DW. WHO Framework Convention on Tobacco Control: a global 'good' for public health. Bull WHO 2000;78:920-9.
6. International Pharmaceutical Federation. FIP statement of policy, the role of the pharmacist in promoting a tobacco free future. The Hague, The Netherlands: International Pharmaceutical Federation; 2003.
7. Department for Tobacco Control. Health and smoking prevalence - the situation in Norway. Oslo Norway: The Department for Tobacco Control, the Prevention Norwegian Directorate for Health and Social Welfare; 2003.
8. Rajamaki H, Katajavuori N, Pietila K. The smokers' perception of health care personnel advice to quit smoking. J Soc Admin Pharm 2003:20:64-71.
9. Norwegian Institute of Public Health. Drug Consumption in Norway 1998-2002. Oslo, Norway: Norwegian Institute of Public Health; 2003.
10. Silagy C, Lancaster T, Stead L, Mant D, Fowler G, Lancaster T. Nicotine Replacement Therapy for Smoking Cessation. (Cochrane Review). In: The Cochrane Library, Issue 2, 2003. Oxford.
11. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med 2003;25:144-53.
12. Sinclair HK, Bond CM, Lennox AS, Taylor RJ, Winfield AJ. Nicotine replacement therapies: smoking cessation outcomes in a pharmacy setting in Scotland. Tobacco Control 1995;4:338-43.
13. Sinclair HK, Bond CM, Lennox AS, Silcock J, Winfield AJ, Donnan PT. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomised controlled trial in Scotland. Tobacco Control 1998;7:253-61.
14. Kennedy DT, Giles JT, Chang ZG, Small RE, Edwards JH. Results of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc 2002;42:51-6.
15. Maguire TA, McElnay JC, Drummond A. A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction 2001:96:325-31.
16. Crealey GE, McElnay JC, Maguire TA, O'Neill C. Costs and effects associated with a community pharmacy-based smoking-cessation programme. Pharmacoeconomics 1998;14:323-33.
17. Isacsson D, Bingefors C, Riboth M. Quit smoking at the pharmacy - an evaluation of a smoking cessation programme in Sweden. J Soc Admin Pharm 1998;15:164-73.
18. Anderson C. A controlled study of the effect of a health promotion training scheme on pharmacists' advice about smoking cessation. J Soc Admin Pharm 1995;12:115-23.
19. De Almeida Neto AC, Benrimoi SI, Kavanagh DJ, Boakes RA. Novel education training program for community pharmacists. Am J Pharm Educ 2000;64:302-7.
20. Morris PT. Purchasing restricted medicines in New Zealand pharmacies: results from a 'mystery shopper' study. Pharm World Sci 2002;24:149-53.
21. Goel PK, Ross-Degnan D, McLaughlin TJ, Soumerai SB. Influence of location and staff knowledge on quality of retail pharmacy prescribing for childhood diarrhea in Kenya. Int J Qual Health Care 1996;8:519-26.
22. Martin Bland J, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;327:307-10.
23. Lange M, Granas AG. Apotekbransjen foer og etter ny apoteklov. Tidsskr Nor Laegeforen 2003;123:3248-9.
24. Gallefoss F, Drangshold K. Smoking enquiry rate and barriers for tobacco prevention among general practitioners in Vest-Agder county. Tidsskr Nor Laegeforen 2002;122:2608-11.
25. Anderson C. Smoking: simple advice is good advice. Pharm J 1998;260:710.
26. Williams DM, Newsom JF, Brock TP. An evaluation of smoking cessation-related activities by pharmacists. J Am Pharm Assoc 2000;40:366-70.
27. Morrow N, Hargie O. An investigation of critical incidents in interpersonal communication in pharmacy practice. J Soc Admin Pharm 1987;4:112-18.
28. Berardo BH, Kimberlin CL, Barnett CW. Observational research on patient education activities of community pharmacists. J Soc Admin Pharm 1989;6:21-30.
29. Morrow N, Hargie O, Donnelly H, Woodman, C. "Why do you ask?" A study of questioning behaviour in community pharmacist-client consultations. Int J Pharm Pract 1993;2:90-4.
30. Tran MT, Holdford DA, Kennedy DT, Small RE. Modeling the cost-effectiveness of a smoking-cessation program in a community pharmacy practice. Pharmacotherapy 2002;22:1623-31.